NCT00955513 - Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Twice or Three Times Daily in Patients With Acute Ankle Sprain | Biotech Hunter

Enrollment

242

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Grade I/II Ankle Sprain

Interventions

DRUG

diclofenac diethylamine gel 2.32%

diclofenac diethylamine gel 2.32% twice a day

DRUG

diclofenac diethylamine gel 2.32%

diclofenac diethylamine gel 2.32% three times a day

DRUG

Placebo

Trial Locations (5)

Novartis Investigative Site, Cologne

Novartis Investigative Site, Essen

Novartis Investigative Site, Gilching

Novartis Investigative Site, Grünwald

Novartis Investigative Site, München